未登录TWO-YEAR EFFECTIVENESS, DURABILITY AND SAFETY OF FARICIMAB IN EYES WITH DIABETIC MACULAR OEDEMA: RESULTS FROM THE UK FARWIDE-DMO STUDYfaricimab在糖尿病黄斑水肿眼中的两年有效性与持久性及安全性：UK FARWIDE-DMO研究的结果
Peto, T.; Kiire, C.; Reynolds, R.; Sivaprasad, S.; Bailey, C.; Downey, L.; Pearce, I.; Chi, G. C.; Darnell, A.; Dayal, P. .png)
分享.png)
收藏PREDICTING ANTI-VEGF OUTCOMES IN CENTRE-INVOLVING DIABETIC MACULAR OEDEMA USING REGRESSION AND MULTIMODAL DEEP LEARNING: A REAL-WORLD NHS COHORT利用回归和多模态深度学习预测中心累及型糖尿病黄斑水肿的抗VEGF治疗效果：一项基于真实世界NHS队列的研究Al-Zubaidy, M.; Stankiewicz, A.; Tsaberiaba, H.; McNally, T.; Rovati, M.; Anderson, M.; Obara, B.; Pohler, R.; Habib, M.; Steel, D. H. W. 分享 收藏 Challenges and Potential Solutions to Advance Global Cancer Drug Development全球癌症药物研发面临的挑战与潜在解决方案Glasmacher, Axel; Lyerly, Kim; Wolf, Birgit; Zapella, Pio; Zielinska, Lidia; Clark, Emma; Mauer, Murielle; Paiva, Bruno; Schiel, Anja; Sweeney, Fergus; Uyl-de Groot, Carin A.; Von Lilienfeld-Toal, Marie; Verweij, Jaap 分享 收藏 分享 收藏 Recommendations for overcoming methodological challenges to health economic modelling that arise when comparing in vitro diagnostics with imaging tests关于克服比较体外诊断与影像学检测时出现的卫生经济模型方法学挑战的建议Watts, Karina; Garay, Osvaldo Ulises; Ferrante di Ruffano, Lavinia; Kittel, Phillip; Gregg, Emily; Heller, Vincent; Watkins, Deborah; Allen, A. Joy; Shinkins, Bethany; Mallet, Sue; Mealing, Stuart; Holmes, Hayden 分享 收藏 Evaluating the statistical utility and information loss in the transformation of a real-world oncology database from CDISC-SDTM to OMOP-CDM评估从CDISC-SDTM到OMOP-CDM转换的真实世界肿瘤学数据库的统计效用和信息损失Lambert, A.; Castagne, C.; Pau, D.; Chmiel, J.; Labarga, A.; Boernert, E.; Margraff, F.; Bachot, C.; Kaczmarek, L.; Toshev, D.; Martinez, J.; Stone, T. 分享 收藏 Evaluation of Current Statistical Methods for Implementing Quality Tolerance Limits当前统计方法在实施质量容差限值中的评估Kilaru, Rakhi; Amodio, Sonia; Li, Yasha; Zeng, Yuling; Khaplonov, Arseny; Wang, Zhongkai; Wells, Christine; Love, Sharon; Rolfe, Tim; Talbot, Susan 分享 收藏 Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patients脑脊液中tominersen浓度的定量关系与亨廷顿病患者的生物标志物变化Yamamoto, Yumi; Silber Baumann, Hanna E.; Bjornsson, Marcus; Grimsey, Paul; Hawellek, David J.; Anderson, Karen; Leavitt, Blair R.; Landwehrmeyer, Bernhard G.; Tabrizi, Sarah; Mccolgan, Peter; Wild, Edward J.; Sanwald Ducray, Patricia 分享 收藏 分享 收藏 Effects of obinutuzumab on urinary renal biomarkers in lupus nephritis: a post hoc exploratory analysis of the phase II nobility study奥滨尤妥珠单抗对狼疮肾炎患者尿肾生物标志物的影响：基于II期NOBILITY研究的回顾性探索性分析Vilet, Juan Manuel Mejia; Clarke, Holly J.; Lanza, Ben; Anania, Veronica; Pendergraft, William F.; Omachi, Theodore A.; Parodis, Ioannis; Jones, Rachel B.; Lightstone, Liz; Rovin, Brad; Raghu, Harini 分享 收藏 分享 收藏 分享 收藏 A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline dataNikolcheva, Tania; Pagano, Gennaro; Pross, Nathalie; Simuni, Tanya; Marek, Kenneth; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Seppi, Klaus; Monnet, Annabelle; Shariati, Nima; Ricci, Benedicte; Rutten-Jacobs, Loes; Respondek, Gesine; Kustermann, Thomas; Taylor, Kirsten I.; Trundell, Dylan; Fontoura, Paulo; Doody, Rachelle; Svoboda, Hanno; Bonni, Azad; Prasinezumab Study Grp 分享 收藏 CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic RetinopathyArmendariz, Beatriz G.; Luhman, Ulrich F. O.; Berger, Brian; Hernandez-Sanchez, Jules; Bogman, Katrijn; Mitrousis, Nikolaos; Wollenhaupt, Martina; Kent, David; Wenzel, Andreas; Fauser, Sascha 分享 收藏 Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part IIITrundell, Dylan; Davies, Evan W.; Barrett, Louise; Zanigni, Stefano; Shariati, Nima; Rogers, Rebecca; Monnet, Annabelle; Moore, Emma; Pross, Nathalie; Pagano, Gennaro; Cano, Stefan; Nikolcheva, Tania 分享 收藏 Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapydelandistrogene moxeparvovec基因治疗后转基因定向免疫介导的肌炎的免疫学研究Potter, Rachael A.; Moeller, Ida H.; Khan, Sohrab; Haegel, Helene; Hollenstein, Andreas; Steiner, Guido; Wandel, Christoph; Murphy, Alexander P.; Asher, Damon R.; Palatinsky, Emanuel; Griffin, Danielle A.; Mason, Stefanie; Iannaccone, Susan T.; Zaidman, Craig M.; Rodino-Klapac, Louise R. 分享 收藏 分享 收藏 Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulationZou, Wenjun; Jiang, Qin; Wang, Yanling; Wei, Wenbin; Sun, Xiaodong; Basu, Karen; Chen, Qiuyu; Kotecha, Aachal; Li, Sijing; Liu, Ruyuan; Patel, Vaibhavi; Chen, Youxin 分享 收藏 Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I studyNewsome, Scott D.; Goldstick, Lawrence; Robertson, Derrick S.; Bowen, James D.; Naismith, Robert T.; Townsend, Ben; Figueiredo, Catarina; Kletzl, Heidemarie; Giraudon, Mylene; Bortolami, Oscar; Zecevic, Dusanka; Giacobino, Caroline; Clinch, Susanne; Shen, Yun-An; Deol-Bhullar, Gurpreet; Bermel, Robert A. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
